Sogen Data · Datasets · 数据专题
肝癌复发轴数据集锦
空转 · bulk 转录组
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源空转
Human · Spatial
-
01 GSE281759 对肝癌患者进行多区域空间转录组分析,比较接受根治性手术切除且术后60个月无复发的患者(A009)与术后3.6-14.0个月出现早期复发的患者(C008、B013、C004)的肿瘤组织差异。采用10x Genomics Visium技术对每个原发肿瘤的2-5个不同区域进行空间转录组检测,至少获取每个区域1个切片;同时对多区域肿瘤扇区开展bulk RNA-seq分析。研究对象包含慢性乙型肝炎病毒阳性与阴性个体,样本涵盖肿瘤组织及相邻正常组织。检测发现INTS6+内皮细胞与肿瘤细胞间存在显著ANGPTL4-SDC1配体-受体相互作用,且在复发病例的原发肿瘤中富集并空间共定位。
设计对肝癌患者进行多区域空间转录组分析,比较接受根治性手术切除且术后60个月无复发的患者(A009)与术后3.6-14.0个月出现早期复发的患者(C008、B013、C004)的肿瘤组织差异。采用10x Genomics Visium技术对每个原发肿瘤的2-5个不同区域进行空间转录组检测,至少获取每个区域1个切片;同时对多区域肿瘤扇区开展bulk RNA-seq分析。研究对象包含慢性乙型肝炎病毒阳性与阴性个体,样本涵盖肿瘤组织及相邻正常组织。检测发现INTS6+内皮细胞与肿瘤细胞间存在显著ANGPTL4-SDC1配体-受体相互作用,且在复发病例的原发肿瘤中富集并空间共定位。
摘要Hepatocellular carcinoma (HCC) exhibits diverse aetiologies and molecular heterogeneities, with a median 5-year overall survival (OS) of less than 70% due to late diagnosis and high recurrence rates post-curative ablation or surgery. This study investigated the complex tumor microenvironment (TME) in HCC, emphasizing the interactions between various cell types and their role in disease recurrence. Using samples from the PLANet 1.0 cohort (NCT03267641), spatial transcriptomics were performed on 17 tissue samples from 4 patients, and bulk RNA-seq on multi-region tumour sectors from 91 patients. Analysis revealed extensive intra- and inter-tumour gene expression heterogeneity, identifying a specific subset of endothelial cells (ECs), INTS6+ ECs, enriched and spatially co-localized with tumour cells in primary tumours of recurrent cases. A significant ANGPTL4-SDC1 ligand-receptor interaction was found between INTS6+ ECs and tumour cells. Interestingly, INTS6+ ECs were enriched in histologically annotated microvascular invasion (MVI). These findings suggest novel therapeutic targets focusing on endothelial cell interactions within TME.
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE10143 对肝癌患者手术切除的肿瘤及周围非肿瘤肝组织进行基因表达分析,以识别与生存相关的基因表达特征。研究包含训练队列(82例日本患者)和验证队列(225例来自美国和欧洲的患者),比较两组非肿瘤肝组织的基因表达差异。
设计对肝癌患者手术切除的肿瘤及周围非肿瘤肝组织进行基因表达分析,以识别与生存相关的基因表达特征。研究包含训练队列(82例日本患者)和验证队列(225例来自美国和欧洲的患者),比较两组非肿瘤肝组织的基因表达差异。
摘要Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (p = 0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlating with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma. This SuperSeries is composed of the SubSeries listed below.
-
02 GSE39791 从72例接受手术切除治疗的肝细胞癌(HCC)患者中,分别采集肿瘤组织和对应的非肿瘤周围组织,提取总RNA并进行基因表达分析。比较肿瘤与非肿瘤组织的基因表达差异,以开发预测术后HCC复发的预后模型。
设计从72例接受手术切除治疗的肝细胞癌(HCC)患者中,分别采集肿瘤组织和对应的非肿瘤周围组织,提取总RNA并进行基因表达分析。比较肿瘤与非肿瘤组织的基因表达差异,以开发预测术后HCC复发的预后模型。
摘要While we and others have uncovered and validated several genomic predictors for metastatic recurrences, a molecular or genomic predictor that can reliably identify high-risk patients for late de novo recurrence has not been firmly established. We analyzed previously reported gene expression data from human livers that underwent partial hepatectomy or transplantation, which were representative physiological conditions that trigger liver regeneration signals. We generated gene expression data from tumor and matched non-tumor surrounding tissues of 72 hepatocellular carcinoma (HCC) patients who underwent surgical resection as the primary treatment. We used these gene expression data to develop a new prognostification model for recurrence of HCC after surgery.
-
03 GSE10140 对肝癌患者术后切除的肿瘤组织和周围非肿瘤肝组织进行基因表达分析,以发现与生存相关的基因表达特征。研究包含82例日本患者的训练队列和225例来自美国及欧洲患者的验证队列,所有样本均为福尔马林固定石蜡包埋的人类肝组织。
设计对肝癌患者术后切除的肿瘤组织和周围非肿瘤肝组织进行基因表达分析,以发现与生存相关的基因表达特征。研究包含82例日本患者的训练队列和225例来自美国及欧洲患者的验证队列,所有样本均为福尔马林固定石蜡包埋的人类肝组织。
摘要Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (p = 0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlating with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma. Keywords: Hepatocellular carcinoma, Expression array, Illumina, Signatures, Outcome prediction
-
04 GSE45114 对肝癌复发患者癌变肝组织与正常肝组织进行转录组分析,比较癌变组织与正常组织的基因表达差异;同时对肝癌患者周围肝组织与正常肝组织进行转录组分析,比较周围组织与正常组织的基因表达差异。
设计对肝癌复发患者癌变肝组织与正常肝组织进行转录组分析,比较癌变组织与正常组织的基因表达差异;同时对肝癌患者周围肝组织与正常肝组织进行转录组分析,比较周围组织与正常组织的基因表达差异。
摘要Hepatocellular carcinoma (HCC) is one of the most malignant and lethal cancers in the world. Its complex process of molecular pathogenesis indicates that HCC is caused by multiple etiological factors and involves multiple types of genes during its development and progression. In the current study, we performed a microarray analysis on the mRNA transcriptome of HCC (C), peri-cancerous liver (P) and normal liver (N) tissues. After integrating these results with information from the Gene Ontology and KEGG Pathway databases, we analyzed the potential interactions between different genes and constructed an interaction network, and identified the regulator, mediator and effector genes in this interaction network.
-
05 GSE214432 对接受手术切除的肝癌患者肝组织进行RNA提取和转录组测序,根据复发状态分为复发组与非复发组,比较两组的转录组特征。
设计对接受手术切除的肝癌患者肝组织进行RNA提取和转录组测序,根据复发状态分为复发组与非复发组,比较两组的转录组特征。
摘要Non-alcoholic fatty liver disease (NAFLD) is a major global health problem with its high prevalence and risk of developing lethal complications, progressive liver fibrosis and hepatocellular carcinoma (HCC), the only rising cancer mortality in the U.S. Ever after curative surgical resection, HCC can recur at extremely high rate (70% within 5 years); therefore, prediction of recurrent HCC is expected to guide decision of neo/adjuvant therapies currently under active development. Herein, we derived an HCC-transcriptome-based signature to predict disseminative recurrence, which originates from disseminated HCC cells from surgically resected initial tumor, and validated it in an independent cohort.
-
06 GSE56545 研究对象为肝癌复发患者及其相邻正常组织、非复发患者的肝癌组织,采用 bulk RNA-seq 技术检测 mRNA 表达,比较复发组与非复发组的差异。
设计研究对象为肝癌复发患者及其相邻正常组织、非复发患者的肝癌组织,采用 bulk RNA-seq 技术检测 mRNA 表达,比较复发组与非复发组的差异。
摘要We did mRNA profiling and showed that an interferon-inducible gene's deletion and under-expression is significantly associated with shorter time to tumor recurrence, shorter progression-free survival, and shorter overall survival in HCC patients.
-
07 GSE169289 对肝癌患者肿瘤组织和配对的邻近组织进行转录组测序,比较两者的基因表达差异。
设计对肝癌患者肿瘤组织和配对的邻近组织进行转录组测序,比较两者的基因表达差异。
摘要Hepatocellular carcinoma is a poor prognosis cancer leading to death, with high rate of recurrence after curative therapy. The functions of Covalently closed circular RNA (circRNAs) in HCC recurrence have remained largely unknown. In this study, we generated multi-omics data to explore the circRNAs involving in the HCC recurrence.
-
08 GSE249913 研究对象为接受肝移植的肝细胞癌(HCC)患者,采集其原发性与复发性肝癌组织样本进行基因表达分析。采用NanoString nCounter Tumor Signaling 360 Panel检测总RNA表达,通过FFPE组织块切片提取RNA,使用RNeasy FFPE Kit进行操作。以七对配对样本(14个总样本)为基础,比较原发性与复发性肝癌的转录组特征差异。
设计研究对象为接受肝移植的肝细胞癌(HCC)患者,采集其原发性与复发性肝癌组织样本进行基因表达分析。采用NanoString nCounter Tumor Signaling 360 Panel检测总RNA表达,通过FFPE组织块切片提取RNA,使用RNeasy FFPE Kit进行操作。以七对配对样本(14个总样本)为基础,比较原发性与复发性肝癌的转录组特征差异。
摘要This study analyzed the clonal evolution at the transcriptomic level during the recurrence of hepatocellular carcinoma (HCC) after liver transplantation, utilizing a rare collection of primary and recurrent tumors.
-
09 GSE164368 针对肝癌肝移植术后复发病例,分析肝癌肿瘤切除样本的基因表达芯片数据,比较复发组(N=6)与非复发组(N=3)的差异,以识别预测复发的分子标志物。
设计针对肝癌肝移植术后复发病例,分析肝癌肿瘤切除样本的基因表达芯片数据,比较复发组(N=6)与非复发组(N=3)的差异,以识别预测复发的分子标志物。
摘要Liver transplantation (LT) for Hepatocellular carcinoma (HCC) can be offered to patients beyond Milan criteria. However, there are currently no molecular markers that can be used on HCC explant histology to predict recurrence, which arises in up to 20% of LT recipients . The goal of our study was to identify proteins on HCC explant predictive of recurrence post-transplant, thereby guiding surveillance strategies and identifying patients beyond Milan criteria who would fare well following LT.
鼠源bulk 转录组
Mouse · Bulk RNA-seq
-
01 GSE303515 将FVB/N-Tg(tetO-Myc)36aBop/J × LAP-tTA转基因小鼠肝组织按 doxycycline 撤除后第3天(D3)、第7天(D7)、肿瘤形成后(T组)、消退第3天(R3)、第7天(R7)及复发阶段(Recurrence)分组,采集各时间点肝样本进行RNA-seq,比较肿瘤进展、消退与复发阶段的基因表达差异。
设计将FVB/N-Tg(tetO-Myc)36aBop/J × LAP-tTA转基因小鼠肝组织按 doxycycline 撤除后第3天(D3)、第7天(D7)、肿瘤形成后(T组)、消退第3天(R3)、第7天(R7)及复发阶段(Recurrence)分组,采集各时间点肝样本进行RNA-seq,比较肿瘤进展、消退与复发阶段的基因表达差异。
摘要Hepatocellular carcinoma (HCC) is a common cancer that frequently overexpresses the c-Myc (Myc) oncoprotein. Using a mouse model of Myc-induced HCC, we studied the metabolic, biochemical, and molecular changes accompanying HCC progression, regression, and recurrence. These involved altered rates of pyruvate and fatty acid β-oxidation and the likely re-directing of glutamine into biosynthetic rather than energy-generating pathways. Initial tumors also showed reduced mitochondrial mass and differential contributions of electron transport chain complexes I and II to respiration. The uncoupling of complex II's electron transport function from its succinate dehydrogenase activity also suggested a mechanism by which Myc generates reactive oxygen species. RNA sequence studies revealed an orderly progression of transcriptional changes involving pathways pertinent to DNA damage repair, cell cycle progression, insulin-like growth factor signaling, innate immunity, and further metabolic re-programming. Only a subset of functions deregulated in initial tumors was similarly deregulated in recurrent tumors thereby indicating that the latter can “normalize” some behaviors to suit their needs. An interactive and freely available software tool was developed to allow continued analyses of these and other transcriptional profiles. Collectively, these studies define the metabolic, biochemical, and molecular events accompanyingHCCevolution, regression, and recurrence in the absence of any potentially confounding therapies.

课题合作 · 扫码加微信
bioinformaticsboy